Bio-Rad Laboratories, Inc. BIO posted fourth-quarter 2024 adjusted earnings per share (EPS) of $2.90, which missed the Zacks ...
Q3 2025 Management View CEO Marc Parent highlighted a record $20.3 billion adjusted backlog, supported by $2.2 billion in new orders during the quarter. Civil segment backlog grew to $8.8 billion, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results